ACBT (4148.TW) monthly revenue, September 2026
ACBT reported revenue of NT$0.37bn for September 2026, down 0.3% from the previous month and up 5.3% from a year earlier. Year-to-date revenue was NT$2.61bn, up 23.1% year on year. It ranked 95 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.37 | -0.3 | 5.3 |